Aberrant SMAD3 signaling in tumor-associated fibroblasts modulates fibrosis and response to the anti-fibrotic drug nintedanib in non-small cell lung cancer

Indexed in

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Reguart Aransay, NoemiAuthorBragado, PalomaAuthorPeinado, VictorAuthorFillat, CristinaAuthor

July 13, 2020

Publications

Meeting Abstract

Publicated to: Cancer Research. 79 (13): 1225-1225 - 2019-07-01 79(13), DOI: 10.1158/1538-7445.AM2019-1225

Authors: Ikemori, Rafael; Gabasa, Marta; Vizoso, Miguel; Duch, Paula; Moran, Sebastian; Gea-Sorli, Sabrina; Bragado, Paloma; Jauset, Toni; Esteller, Manel; Soucek, Laura; Monso, Eduard; Peinado, Victor; Fillat, Cristina; Hilberg, Frank; Reguart, Noemi; Alcaraz, Jordi

Affiliations

2 ;‎ Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain - Author

3 ;‎ Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain - Author

4 ;‎ Vall Hebron Inst Oncol VHIO, Barcelona, Spain - Author

5 ;‎ Hosp Parc Tauli Sabadell, Sabadell, Spain - Author

6 ;‎ Boehringer Ingelheim Inc, Vienna, Austria - Author

7 ;‎ Hosp Clin Barcelona, Barcelona, Spain - Author

1 ;‎ Univ Barcelona, Barcelona, Spain - Author

Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain - Author

Boehringer Ingelheim Inc, Vienna, Austria - Author

Hosp Clin Barcelona, Barcelona, Spain - Author

Hosp Parc Tauli Sabadell, Sabadell, Spain - Author

Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain - Author

Univ Barcelona, Barcelona, Spain - Author

Vall Hebron Inst Oncol VHIO, Barcelona, Spain - Author

Keywords

Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Cancer Research due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2019, it was in position 19/244, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology. Notably, the journal is positioned above the 90th percentile.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Austria.

Indexed in

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Share